Orgenesis (ORGS) Short Interest Ratio & Short Volume → How Biden has already won 2024 (From Porter & Company) (Ad) Free ORGS Stock Alerts $0.53 -0.03 (-5.35%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Orgenesis Short Interest DataCurrent Short Volume288,100 sharesPrevious Short Volume402,500 sharesChange Vs. Previous Month-28.42%Dollar Volume Sold Short$145,605.74Short Interest Ratio / Days to Cover1.3Last Record DateApril 30, 2024Outstanding Shares34,380,000 sharesPercentage of Shares Shorted0.84%Today's Trading Volume16,892 sharesAverage Trading Volume32,142 sharesToday's Volume Vs. Average53% Short Selling Orgenesis ? Sign up to receive the latest short interest report for Orgenesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatORGS Short Interest Over TimeORGS Days to Cover Over TimeORGS Percentage of Float Shorted Over Time Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic Orgenesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024288,100 shares $145,605.74 -28.4%N/A1.3 $0.51 4/15/2024402,500 shares $201,129.25 +34.3%N/A1.7 $0.50 3/31/2024299,700 shares $246,353.40 -7.0%N/A1.9 $0.82 3/15/2024322,200 shares $254,280.24 +42.8%N/A2.2 $0.79 2/29/2024225,700 shares $144,493.14 -7.4%N/A1.5 $0.64 2/15/2024243,800 shares $117,024.00 +61.6%N/A1.7 $0.48 Get the Latest News and Ratings for ORGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024150,900 shares $47,382.60 +25.2%N/A1.6 $0.31 1/15/2024120,500 shares $36,029.50 -36.4%N/A1.3 $0.30 12/31/2023189,500 shares $94,882.65 +47.0%N/A2.4 $0.50 12/15/2023128,900 shares $63,844.17 -39.3%N/A1.8 $0.50 11/30/2023212,300 shares $97,997.68 -12.2%N/A3.4 $0.46 11/15/2023241,900 shares $133,045.00 +21.5%N/A2.4 $0.55 10/31/2023199,100 shares $135,407.91 -18.7%0.8%1.8 $0.68 10/15/2023244,800 shares $206,537.76 +18.4%1.0%2.5 $0.84 9/30/2023206,800 shares $128,216.00 -29.0%0.9%2.1 $0.62 9/15/2023291,400 shares $201,066.00 +45.4%1.2%3.1 $0.69 8/31/2023200,400 shares $102,023.64 +2.4%0.9%2.3 $0.51 8/15/2023195,700 shares $192,568.80 +8.6%N/A4.4 $0.98 7/31/2023180,200 shares $196,418.00 -13.3%N/A6.5 $1.09 7/15/2023207,900 shares $270,270.00 -7.2%N/A7.1 $1.30 6/30/2023224,100 shares $311,499.00 +13.6%N/A7.4 $1.39 6/15/2023197,200 shares $256,360.00 -1.0%N/A5.5 $1.30 5/31/2023199,100 shares $236,929.00 +6.9%N/A4.4 $1.19 5/15/2023186,300 shares $199,359.63 -11.5%N/A2.4 $1.07 4/30/2023210,600 shares $231,660.00 -43.4%N/A2.8 $1.10 4/15/2023372,100 shares $427,915.00 -17.2%N/A5 $1.15 3/31/2023449,600 shares $530,528.00 +47.5%N/A5.9 $1.18 3/15/2023304,800 shares $377,952.00 -19.1%1.3%4.3 $1.24 2/28/2023376,800 shares $542,592.00 +91.0%1.6%6.3 $1.44 2/15/2023197,300 shares $420,249.00 +0.4%1.0%3.4 $2.13 1/31/2023196,600 shares $471,840.00 -12.7%1.0%1.8 $2.40 1/15/2023225,100 shares $535,738.00 +2.4%1.1%2 $2.38 12/30/2022219,800 shares $428,610.00 +4.9%1.0%2 $1.95 12/15/2022209,500 shares $427,380.00 -5.1%1.0%1.9 $2.04 11/30/2022220,800 shares $441,600.00 -25.9%1.0%2.1 $2.00 11/15/2022298,000 shares $643,680.00 +53.8%1.4%2.9 $2.16 10/31/2022193,800 shares $259,692.00 +2.1%0.9%1.8 $1.34 10/15/2022189,900 shares $241,173.00 -4.7%0.8%5.1 $1.27 9/30/2022199,300 shares $283,006.00 +28.5%0.9%5.8 $1.42 9/15/2022155,100 shares $285,384.00 -9.9%0.7%4.8 $1.84Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. ORGS Short Interest - Frequently Asked Questions What is Orgenesis' current short interest? Short interest is the volume of Orgenesis shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 288,100 shares of ORGS short. Learn More on Orgenesis' current short interest. What is a good short interest ratio for Orgenesis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGS shares currently have a short interest ratio of 1.0. Learn More on Orgenesis's short interest ratio. Is Orgenesis' short interest increasing or decreasing? Orgenesis saw a decline in short interest in April. As of April 30th, there was short interest totaling 288,100 shares, a decline of 28.4% from the previous total of 402,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Orgenesis' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Orgenesis: Lumos Pharma, Inc. (6.09%), Alaunos Therapeutics, Inc. (9.57%), MEI Pharma, Inc. (0.37%), Synlogic, Inc. (0.36%), BioVie Inc. (3.18%), NeuroBo Pharmaceuticals, Inc. (2.06%), Benitec Biopharma Inc. (6.27%), KALA BIO, Inc. (0.36%), Cumberland Pharmaceuticals Inc. (0.23%), Cocrystal Pharma, Inc. (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Orgenesis stock? Short selling ORGS is an investing strategy that aims to generate trading profit from Orgenesis as its price is falling. ORGS shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orgenesis? A short squeeze for Orgenesis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGS, which in turn drives the price of the stock up even further. How often is Orgenesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Lumos Pharma Short Interest Alaunos Therapeutics Short Interest MEI Pharma Short Interest Synlogic Short Interest BioVie Short Interest NeuroBo Pharmaceuticals Short Interest Benitec Biopharma Short Interest KALA BIO Short Interest Cumberland Pharmaceuticals Short Interest Cocrystal Pharma Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORGS) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsHow Biden has already won 2024Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis is bad news for Biden…The Freeport Society348 million Americans lives to END as we know it?The Oxford Club